Contineum Therapeutics, Inc. (CTNM) Misses Q1 EPS by 20c
Tweet
Share
E-mailGet Alerts CTNM Hot Sheet
Join SI Premium – FREE
Contineum Therapeutics, Inc. (NASDAQ: CTNM) reported Q1 EPS of ($0.62), $0.20 worse than the analyst estimate of ($0.42).
For earnings history and earnings-related data on Contineum Therapeutics, Inc. (CTNM) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Sphere Entertainment (SPHR) Reiterated at Market Outperform by Citizens: Global Expansion Apace
- Goldman Sachs sees refinery exemptions boosting DK cash flow
- Citi raises Atlassian price target to $225, maintains Buy rating
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
